Neuralink has now asked people to register through its Patient Registry as it gets ready to begin human trials.

Neuralink is now in line for prioritised review for the device’s submission and will also be able to interact quickly with ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Elon Musk announced plans to make Neuralink's brain-computer interface technology "widely available" following the company's ...

Neuralink, Elon Musk's neurotechnology company, has achieved a significant milestone by receiving Breakthrough Device ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore communication for ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...